Cardiac involvement in adult polymyositis or dermatomyositis: A systematic review

Clinical Cardiology

Volumn 35, Issue 11, 2012, Pages 685-691

  Lu, Zhang ^a   Guo Chun, Wang ^b   Li, Ma ^b   Ning, Zu ^b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NITRATE;

ATRIOVENTRICULAR BLOCK; CAUSE OF DEATH; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEATH; DERMATOMYOSITIS; ELECTROCARDIOGRAM; HEART; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERKINETIC HEART SYNDROME; HYPERKINETIC LEFT VENTRICULAR CONTRACTION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MEDLINE; MUSCLE ATROPHY; MUSCLE NECROSIS; MYOCARDITIS; PACEMAKER; PERICARDIAL EFFUSION; POLYMYOSITIS; PROGNOSIS; REVIEW; SKELETAL MUSCLE; SYSTEMATIC REVIEW;

EID: 84869503155     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22026     Document Type: Review

References (35)

1. Oppenheim HZ., Dermatomyostitis. Berl klin Wochenschrift. 1899: 805-807.
2. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996; 14: 373-379. (Pubitemid 26257588)
3. Taylor AJ, Wortham DC, Burge JR, et al. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol. 1993; 16: 802-808. (Pubitemid 23335118)
4. Bohan A, Peter JB, Bowman RL, et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977; 56: 255-286. (Pubitemid 8130612)
5. Lundberg IE., The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006; 45 (suppl 4): iv18-iv21. (Pubitemid 44446758)
6. Danko K, Ponyi A, Constantin T., Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features. Medicine (Baltimore). 2004; 83: 35-42. (Pubitemid 38124854)
7. Hochberg MC, Feldman D, Stevens MB., Adult onset polymyositis/ dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986; 15: 168-178. (Pubitemid 16132225)
8. Denbow CE, Lie JT, Tancredi RG, et al. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum. 1979; 22: 1088-1092. (Pubitemid 10161246)
9. Benenbassat J, Gefel D, Larholt K., Progognostic factors in polymyositis/dermatomyosits. Arthritis Rheum. 1985; 28: 249-255.
10. Kehoe RF, Robert B, Carl T., Cardiac conduction defects in polymyositis. Ann Intern Med. 1981; 94: 41-43.
11. Stern R, Godbold JH, Chess Q, et al. ECG abnormalities in polymyositis. Arch Intern Med. 1984; 144: 2185-2189. (Pubitemid 15215509)
12. Haupt HM, Hutchins GM., The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982; 50: 998-1006. (Pubitemid 13232021)
13. Wilhelmina MHB, Behan Po, Gairns IJ. Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Br Heart J. 1987; 57: 176-180.
14. Byrnes TJ, Baethge BA, Wolf RE., Noninvasive cardiovascular studies in patients with inflammatory myopathy. Angiology. 1991; 42: 843-848.
15. Gottdiener JS, Sherber HS, Hawley RJ, et al. Cardiac manifestations in polymyositis. Am J Cardiol. 1978, 41: 1141-1149. (Pubitemid 8371752)
16. Allanore Y, Vignaux O, Arnaud L, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis. 2006; 65: 249-252. (Pubitemid 43132003)
17. Buchpiguel CA, Roizemblatt S, Pastor EH, et al. Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications. Eur J Nucl Med. 1996; 23: 199-203. (Pubitemid 26056999)
18. Agrawal CS, Behari M, Shrivastava S, et al. The heart in polymyositis-dermatomyositis. J Neurol. 1989; 236: 249-250. (Pubitemid 19144811)
19. Strongwater SL, Annesley T, Schnitzer TJ., Myocardial involvement in polymyositis. J Rheumatol. 1983; 10: 459-463. (Pubitemid 13014435)
20. Plazak W, Kopeec G, Tomkiewica-Pajak L., Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study. Acta Cardiol. 2011; 66: 159-165.
21. Hebert CA, Byrnes TJ, Baethge BA, et al. Exercise limitation in patients with polymyositis. Chest. 1990; 98: 352-357. (Pubitemid 20247971)
22. Askari AD., Inflammatory disorders of muscle. Cardiac abnormalities. Clin Rheum Dis. 1984; 10: 131-149. (Pubitemid 14141237)
23. Vidya SL, Sue L, Peter B, et al. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis. 2010; 13: 132-137.
24. Tisseverastinghe A, Bernatsky S, Christian AP., Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol. 2009; 36: 1943-1946.
25. Oka M, Raasakka T., Cardiac involvement in polymyositis. Scand J Rheumatol. 1978; 7: 203-208. (Pubitemid 9102969)
26. Vander PJ, Hengstman GJ, LaaK T, et al. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2004; 75: 136-139. (Pubitemid 38091283)
27. Englund P, Nennesmo I, Klareskog L, et al. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum. 2002; 46: 1044-1055. (Pubitemid 34303818)
28. Kiely PD, Bruckner FE, Nisbet JA, et al. Serum skeletal troponin I in inflammatory muscle disease: relation to creatione kinase, CKMB and cardiac troponin. Ann Rheum Dis. 2000; 59: 750-751.
29. Rasmussen LH, Madsen HN, Ladefoged SD., Creatine phosphokinase MB and lactate dehydrogenase isoenzyme 1 in polymyositis. Scand J Rheumatol. 1985; 14: 427-430. (Pubitemid 16207450)
30. Petra E, Angelika L, Jurgen F, et al. Cardiac troponin and b-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clinica Chimica Acta. 2001; 306: 27-33.
31. Touma Z, Arayssi T, Kibbi L, et al. Successful treatment of cardiac involvement in dermatomyositis with rituximab. Joint Bone Spine. 2008; 75: 334-337. (Pubitemid 351609418)
32. Afzal A, RSD H, Philbin EF., Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart. 1999; 82: e4.
33. Corinne F, Sumeet A, Way MW, et al. Clinical observations on the significance of raised cardiac troponin-T in patients with myositis of varying etiologies seen in rheumatology practice. Clin Rheumatol. 2010; 29: 1107-1111.
34. Na S, Kim SM, Sunwoo N., Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009; 24: 715-721.
35. Sharratt GP, Danta G, Carson PH., Cardiac abnormality in polymyositis. Ann Rheum Dis. 1977; 36: 575-578.